These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26898814)

  • 1. SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists.
    He S; Dobbelaar PH; Guo L; Ye Z; Liu J; Jian T; Truong Q; Shah SK; Du W; Qi H; Bakshi RK; Hong Q; Dellureficio JD; Sherer E; Pasternak A; Feng Z; Reibarkh M; Lin M; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Fernandez G; Nelson D; Bunting P; Kerr J; Fitzgerald P; Morissette P; Volksdorf S; Eiermann GJ; Li C; Zhang BB; Howard AD; Zhou YP; Nargund RP; Hagmann WK
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1529-1535. PubMed ID: 26898814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists.
    He S; Lai Z; Ye Z; Dobbelaar PH; Shah SK; Truong Q; Du W; Guo L; Liu J; Jian T; Qi H; Bakshi RK; Hong Q; Dellureficio J; Reibarkh M; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Fernandez G; Nelson D; Bunting P; Kerr J; Fitzgerald P; Morissette P; Volksdorf S; Eiermann GJ; Li C; Zhang B; Howard AD; Zhou YP; Nargund RP; Hagmann WK
    ACS Med Chem Lett; 2014 Jul; 5(7):748-53. PubMed ID: 25050159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes.
    Shah SK; He S; Guo L; Truong Q; Qi H; Du W; Lai Z; Liu J; Jian T; Hong Q; Dobbelaar P; Ye Z; Sherer E; Feng Z; Yu Y; Wong F; Samuel K; Madiera M; Karanam BV; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Feng Y; Wu M; Shao Q; Trujillo ME; Eiermann GJ; Li C; Pachanski M; Fernandez G; Nelson D; Bunting P; Morissette P; Volksdorf S; Kerr J; Zhang BB; Howard AD; Zhou YP; Pasternak A; Nargund RP; Hagmann WK
    ACS Med Chem Lett; 2015 May; 6(5):513-7. PubMed ID: 26005524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antischistosomal tetrahydro-γ-carboline sulfonamides.
    Ren R; Wang X; Leas DA; Häberli C; Cal M; Dong Y; Kaiser M; Keiser J; Vennerstrom JL
    Bioorg Med Chem Lett; 2022 Mar; 59():128546. PubMed ID: 35031451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
    Poitout L; Roubert P; Contour-Galcéra MO; Moinet C; Lannoy J; Pommier J; Plas P; Bigg D; Thurieau C
    J Med Chem; 2001 Aug; 44(18):2990-3000. PubMed ID: 11520208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
    Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
    Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel 5,8-disubstituted-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles as 5-HT(6) and H(1) receptors antagonists.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Tkachenko SE
    Arch Pharm (Weinheim); 2009 Dec; 342(12):740-7. PubMed ID: 19921682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.
    Audia JE; Evrard DA; Murdoch GR; Droste JJ; Nissen JS; Schenck KW; Fludzinski P; Lucaites VL; Nelson DL; Cohen ML
    J Med Chem; 1996 Jul; 39(14):2773-80. PubMed ID: 8709108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Substituted 2,3,4,5-tetrahydro-1H-gamma-carbolines: new antagonists of histamine H1 receptors].
    Ivashchenko AV; Mit'kin OD; Okun' IM; Salimov RM; Fedotov IuA
    Eksp Klin Farmakol; 2010 Nov; 73(11):25-9. PubMed ID: 21254595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tetrahydro-beta-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).
    Trujillo JI; Meyers MJ; Anderson DR; Hegde S; Mahoney MW; Vernier WF; Buchler IP; Wu KK; Yang S; Hartmann SJ; Reitz DB
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4657-63. PubMed ID: 17570666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective preparation of pyridoxal 1,2,3,4-tetrahydro-β-carboline derivatives and the influence of their absolute and relative configuration on the proliferation of the malaria parasite Plasmodium falciparum.
    Brokamp R; Bergmann B; Müller IB; Bienz S
    Bioorg Med Chem; 2014 Mar; 22(6):1832-7. PubMed ID: 24565970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of β-carbolines on platelet aggregation and lipid membranes.
    Tsuchiya H; Ohmoto S
    Pharmacol Rep; 2010; 62(4):689-95. PubMed ID: 20885009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
    Khorana N; Smith C; Herrick-Davis K; Purohit A; Teitler M; Grella B; Dukat M; Glennon RA
    J Med Chem; 2003 Aug; 46(18):3930-7. PubMed ID: 12930153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aryl-1-piperazinylalkyl derivatives of 1,2,3,4-tetrahydro-beta-carboline ring system. Synthesis and preliminary in vivo studies.
    Cegła MT; Boksa J; Chojnacka-Wójcik E; Misztal S
    Pharmazie; 1996 Dec; 51(12):932-6. PubMed ID: 8985983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral and fungicidal activity evaluation of β-carboline, dihydro-β-carboline, tetrahydro-β-carboline alkaloids, and their derivatives.
    Song H; Liu Y; Liu Y; Wang L; Wang Q
    J Agric Food Chem; 2014 Feb; 62(5):1010-8. PubMed ID: 24460429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies of beta-carboline analogs.
    Lawson JA; Uyeno ET; Nienow J; Loew GH; Toll L
    Life Sci; 1984 May; 34(21):2007-13. PubMed ID: 6328151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
    Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 1,2,3,4-tetrahydro-beta-carboline derivatives as hepatoprotective agents. III. Introduction of substituents onto methyl 1,2,3,4-tetrahydro-beta-carboline-2-carbodithioate.
    Saiga Y; Iijima I; Ishida A; Miyagishima T; Homma K; Oh-ishi T; Matsumoto M; Matsuoka Y
    Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3284-91. PubMed ID: 3427712
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and in vitro cytotoxic evaluation of 1,3-bisubstituted and 1,3,9-trisubstituted beta-carboline derivatives.
    Cao R; Peng W; Chen H; Hou X; Guan H; Chen Q; Ma Y; Xu A
    Eur J Med Chem; 2005 Mar; 40(3):249-57. PubMed ID: 15725494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytochemical meanings of tetrahydro-β-carboline moiety in strictosidine derivatives.
    Sudžuković N; Schinnerl J; Brecker L
    Bioorg Med Chem; 2016 Feb; 24(4):588-95. PubMed ID: 26749326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.